Discontinued — last reported Q3 '23
Over 4 years (FY 2020 to FY 2024), Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) shows a downward trend with a -100.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | |
|---|---|---|---|---|
| Value | $95.00M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — | — |
| YoY Change | — | -100.0% | — | — |